Clinical Trials Logo

Enterovirus 71 Infection clinical trials

View clinical trials related to Enterovirus 71 Infection.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT03865238 Completed - Clinical trials for Enterovirus 71 Infection

A Study to Evaluate the Efficacy, Safety, and Immunogenicity of an EV71 Vaccine

Start date: April 23, 2019
Phase: Phase 3
Study type: Interventional

Subjects will receive the first IM injection of study vaccine on Day 1 and will receive a second dose 56 days later. A booster vaccine will be given 365 days after the first dose in subjects 2 months to < 2 years of age. The last study visit is on Day 422 when subjects will be contacted via telephone / home visit system to assess for adverse events and concomitant medications.